Guoxing Zheng

Title: Guoxing Zheng: Innovator in Protein Transfer Technologies

Introduction

Guoxing Zheng is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of protein transfer technologies, holding 2 patents that focus on innovative methods for transferring proteins to cells. His work has implications for cancer treatment and autoimmune diseases.

Latest Patents

Zheng's latest patents include "Auto-stimulating cells and methods for making and using the same" and "Method for protein transfer." These patents disclose methods for transferring one or more proteins to a cell in the form of a fusion protein. The fusion protein contains at least one domain encoding for a protein or peptide with trans signaling and/or adhesion functions. The transfer process involves binding the fusion protein to a lipidated protein incorporated into the cell membrane. Additionally, these methods can be utilized in cancer vaccines, treatment of cancer or autoimmune diseases, and determining costimulator threshold levels.

Career Highlights

Throughout his career, Guoxing Zheng has worked with esteemed organizations such as the University of Pennsylvania and Tr Associates, L.L.C. His experience in these institutions has allowed him to develop and refine his innovative approaches to protein transfer.

Collaborations

Zheng has collaborated with notable colleagues, including Mark L. Tykocinski and Aoshuang Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Guoxing Zheng's work in protein transfer technologies represents a significant advancement in the field of biomedical research. His innovative methods hold promise for improving treatment options for various diseases, particularly cancer and autoimmune disorders.